News Oxford Nanopore's tech reaches genome sequencing landmark Oxford Nanopore one of many firms cutting time and cost of sequencing
News Lundbeck trial investigates genetic causes of depression New study with 23andMe and Milken Institute looks to determine causes of depression.
Views & Analysis Hospital uses AI to embrace clinical genomics AI can sift and analyse vast amounts of genomic data, enabling clinical scientists to better diagnose patients.
News FDA approval for 23andMe's direct-to-consumer genetics test Service can now be marketed as test for Alheimer's and Parkinson's, among others.
News Regeneron and GSK to sequence UK genetic data Companies to sequence data from 500,000 volunteers from UK's Biobank.
News Fulcrum Therapeutics promises new drugs for rare disorders Company launched following $55 million series A funding round.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
